WHO’s Latest Gift to the Plebs: Another Apocalyptic Scare, Courtesy of a Rat-Infested Cruise Ship

The little Dutch-flagged MV Hondius with 147 passengers and crew from 23 countries that left Ushuaia, Argentina on April 1 for its Antarctic jaunt (Crazy coincidence with the newest WHO exercise called Polaris II.).

Three elderly passengers dead (the 70-year-old Dutch man and his 69-year-old wife in a Johannesburg hospital, and a German national - age undisclosed), a handful more PCR-positive for the Andes Hantavirus strain, which just happens to be endemic to southern South America where the ship kicked off its voyage.

The rest quarantined in their cabins somewhere off the Canary Islands after the vessel fled Cape Verde.

A bit of rare person-to-person transmission for extra spice.

Terrifying. Must-watch.

Right on schedule, the Alien Larvae Graphene Covid Guys have swarmed out of their basements.

The same crowd who spent half a decade insisting mRNA shots were pumping alien larvae and self-assembling nanotech into our veins are now triumphantly waving Pfizer’s old adverse-event list, circling “Hantavirus pulmonary infection” in red and screaming “WE TOLD YOU SO!” as if a South American rodent virus on a cruise ship is the smoking gun that finally proves their five-year apocalypse fanfic.

They’re getting the clicks.

(There are enough reasons to go after mRNA technology, but graphene and aliens aren’t among them.)

We, the grateful plebs, are honestly thrilled for the distraction.

Because while everyone’s glued to the floating rat plague and the graphene warriors’ victory lap, the WHO is quietly rolling out the next phase of its Global Digital Health Certification Network - shiny new digital health wallets being pushed through under the ever-so-humble banner of “pandemic preparedness.”

One app. Your entire medical life. Vaccination records, test results, future boosters, all cryptographically verified and shareable across borders, and absolutely secure™.

Started as COVID passes. Now permanent infrastructure. For your safety, obviously.

Once your state-issued digital ID lives in the same wallet as your health pass, you can kiss the anonymous internet goodbye.

Post a meme, comment on a thread, book a flight, open a bank account - AI will know it’s really you, cross-checked against your government profile in real time.

No more pseudonyms.

No more cash.

No more off-grid opinions.

Just one seamless, trackable, programmable identity shared openly, like those 57 million health records casually strolled out in 2025 alone (Aflac, Yale New Haven, Episource… take your pick), or last week’s comedy gold where nearly every U.S. state health exchange got caught piping your name, race, citizenship status and medical details straight to Meta, TikTok and Google, and several other personal data leaks we've been reporting on previously.

The ship will dock, the retirees will disembark.

The Graphene Guys will move on to the next shiny thing.

Soon, you will happily post on state-approved social media with your real ID, knowing you are fully protected from Hantavirus - and every other threat the WHO deems worthy of our attention.

~

No approved vaccines exist for widespread use against New World hantaviruses like the Andes strain implicated in the MV Hondius outbreak, which triggers hantavirus pulmonary syndrome (HPS) with high fatality rates across the Americas.

Old World strains responsible for hemorrhagic fever with renal syndrome (HFRS) have a few regionally licensed options, such as Hantavax - an inactivated Hantaan virus vaccine developed in South Korea in the 1990s and used in South Korea and China, but these are strain-specific, show limited broad efficacy, and are not approved in Europe or the US.

Inactivated vaccines targeting Hantaan (HTNV) and Seoul (SEOV) viruses exist in parts of Asia but offer no protection against Andes or other New World variants.

Development of new candidates focuses on DNA, mRNA, protein subunit, and viral-vectored platforms aimed at the Gn/Gc glycoproteins to elicit neutralizing antibodies, though most remain preclinical or in early clinical stages as of 2026.

US Army-led DNA vaccines have completed Phase 1 trials for HTNV and Puumala (PUUV) with promising safety and immunogenicity data, and Phase 2a dosing studies are underway, but these target HFRS rather than HPS.

A Korea University / Moderna mRNA collaboration announced in 2024 is exploring broader coverage in preclinical work, while 2026 high-resolution structures of Andes virus glycoprotein tetramers from UT Austin have enabled a preclinical candidate that protected mice.

Other efforts include Canada’s VIDO (mRNA, stabilized subunit, and Newcastle Disease virus-vectored intranasal candidates for HPS in hamster models), Modified Vaccinia Ankara (MVA) multi-valent vectors showing reduced viral loads in mice, and various nucleic acid platforms.

No Andes-specific candidates have reached Phase 3 trials; hantavirus diversity makes a universal vaccine difficult, so any rollout remains years away.

Treatment stays supportive (primarily ventilation - haven't we heard this before), with ribavirin offering only mixed results.

Source: https://www.hipaajournal.com/largest-healthcare-data-breaches-of-2025/

Disclaimer: This is a satirical piece. vlgr is not a real news outlet - it's parody and exaggeration for entertainment purposes only